CNMD vs GKOS Stock Comparison
CNMD currently leads GKOS in this stock comparison, with AIQ scores of 71 vs 65. The clearest difference is value, while GKOS has the stronger momentum profile.
What is the main difference between CNMD and GKOS?
CNMD leads the current stock comparison as CONMED Corporation, with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
CONMED Corporation vs Glaukos Corporation
CNMD leads
CNMD leads by 6 AIQ points, primarily on Value, but the lead has narrowed from 9 points over 30 sessions.
Fragile: 3 of 6 evidence groups support CNMD, its lead is narrowing, and its current signal state is conflicted.
CONMED Corporation
Glaukos Corporation
The Algovestiq AIQ Score currently favors CNMD over GKOS, 71 versus 65 as of Nov 18, 2026. CNMD's advantage is driven primarily by stronger value, while GKOS holds the stronger momentum profile. CNMD also shows the weaker technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor CNMD today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. CNMD lead: Weakening — the AIQ differential moved from 9 to 6 points over 30 sessions.
Compare CONMED Corporation and Glaukos Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare CNMD and GKOS against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value84 vs 30CNMD +54
- Momentum74 vs 90GKOS +16
- Quality66 vs 64Even
- Risk Resilience58 vs 57Even
3 of 6 evidence groups favor CNMD. CNMD’s edge is concentrated in value; GKOS keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.
Largest factor move: Momentum -2
No signal started or stopped since the prior session; its 7 active signals are unchanged.
Largest factor move: Momentum -1
New signals
- Stochastic Overbought Rollover — bearish, momentum, short horizon
CNMD's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — CNMD and GKOS both carry a full feed there.
The central trade-off
CNMD (CONMED Corporation): the stronger current systematic profile, led by value.
GKOS (Glaukos Corporation): the counter-case, on momentum, fundamentals, technicals — but at materially higher volatility, 130.4% against 62.2%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CNMDCNMD on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
GKOSGKOS on combined revenue and EPS growth.
Value
CNMDCNMD on the peer-relative Value factor, by 54 points.
Momentum
GKOSGKOS on the Momentum factor, by 16 points.
Lower downside
CNMDCNMD carries the lower 1-month annualized volatility.
Analyst upside
CNMDCNMD on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | CNMD | GKOS | Note |
|---|---|---|---|
| Implied upside to target | +4.1% | +0.4% | CNMD has more room |
| Target dispersion | 0% | +21.4% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 7 | 13 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor CNMD. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | CNMD | 71 vs 65 |
| Fundamentals | GKOSon balance | revenue growth -2.3% vs 13.7%; EPS growth -14.3% vs 109.7%; TTM ROE 1.9% vs 0.3%; gross margin 57.2% vs 81.1%; operating margin 12.1% vs -9.2% — GKOS takes 3 of 5 decided legs, not all of them |
| Valuation | CNMD | Value 84 vs 30 |
| Technicals | GKOS | Price vs 50-day 1.8% vs 26.3%; vs 200-day 20.7% vs 66.9% |
| Risk Resilience | Even | Risk Resilience 58 vs 57 |
| Analyst expectations | CNMD | Target upside 4.1% vs 0.4% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CNMD and GKOS and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 6 points.
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CNMD.
How the comparison changed
120 daily snapshots · Jun 1 – Nov 18CNMD lead: Weakening — the AIQ differential moved from 9 to 6 points over 30 sessions.
- Today
- CNMD +6
- 71 vs 65
- 7 sessions ago
- CNMD +7
- 73 vs 66
- 30 sessions ago
- CNMD +9
- 71 vs 62
- 90 sessions ago
- CNMD +5
- 69 vs 64
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 1 bearish / 2 neutral, conflicted
No signal that the other name lacks.
6 bullish / 3 bearish / 2 neutral, conflicted
Only GKOS
- 52-Week High Proximity — bullish, risk_regime, long horizon (2.4%)
- Keltner Channel Breakout — bullish, volatility, short horizon
- RSI Bearish Divergence — bearish, momentum, medium horizon
- Stochastic Overbought Rollover — bearish, momentum, short horizon
Both carry 7 more signals that do not separate them: Golden Cross Active, ADX Trend Strengthening, ATR Expansion - Breakout Mode, EMA Ribbon Expansion Bullish, Low Volume Rally Warning, TRIX Bullish Signal, Uptrend Structure Active.
CNMD leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved down over the latest session (price -0.79%, AIQ -1 points).
Price and the AIQ Score both moved down over the latest session (price -4.18%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1GKOS closes the Value gap — currently 54 points behind, the largest single contributor to CNMD's edge.
- 2GKOS generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover.
- 3CNMD's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
- 4The narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 6-point move would eliminate CNMD's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
GKOS leads on balance| Metric | CNMD | GKOS |
|---|---|---|
| Revenue growth (YoY) | -2.3% | 13.7% |
| EPS growth (YoY) | -14.3% | 109.7% |
| Gross margin | 57.2% | 81.1% |
| Operating margin | 12.1% | -9.2% |
| Return on equity (TTM) | 1.9% | 0.3% |
| Debt to equity | 0.77 | 0.14 |
Performance
GKOS leads 6 of 6 windows| Metric | CNMD | GKOS |
|---|---|---|
| 1 week (5 sessions) | -1.8% | 9.5% |
| 1 month (20 sessions) | 8.3% | 49.1% |
| 3 months (63 sessions) | 2.7% | 32.4% |
| 6 months (126 sessions) | 42.5% | 70.6% |
| Year to date | 24.6% | 117.6% |
| 1 year (252 sessions) | 16.1% | 165.3% |
Technicals
GKOS has the stronger structure| Metric | CNMD | GKOS |
|---|---|---|
| RSI (14) | 56.8 | 68.7 |
| ADX (14) | 23.3 | 41.2 |
| Price vs 50-day | 1.8% | 26.3% |
| Price vs 200-day | 20.7% | 66.9% |
| Volatility (1M, annualized) | 62.2% | 130.4% |
Risk
Split| Metric | CNMD | GKOS |
|---|---|---|
| Beta | 0.79 | 1.06 |
| Sharpe ratio | 0.48 | 1.83 |
| Sortino ratio | 0.76 | 3.79 |
| Max drawdown | -30.3% | -28.4% |
| Current drawdown | -5.7% | -0.6% |
| Annualized volatility | 47% | 61.4% |
| Value at risk (95%) | -4% | -4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CNMD or GKOS?
On the Algovestiq AIQ Score, CNMD is the stronger of the two as of Nov 18, 2026, scoring 71 against GKOS's 65. The edge comes from value. GKOS is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CNMD or GKOS the better buy right now?
CNMD carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor CNMD over GKOS?
The composite weights Quality, Value, Momentum and Risk Resilience. CNMD leads Value by 54 points; GKOS leads Momentum by 16 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CNMD or GKOS?
Analyst price targets imply +4.1% upside for CNMD and +0.4% for GKOS, so the Street currently favors CNMD. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CNMD or GKOS?
CNMD is the better-valued of the two on the peer-relative Value factor. CNMD on the peer-relative Value factor, by 54 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CNMD or GKOS?
GKOS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CNMD or GKOS?
GKOS on the Momentum factor, by 16 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CNMD or GKOS?
CNMD is the more resilient of the two, so the other name carries the higher downside risk. CNMD carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CNMD more profitable than GKOS?
The profitability evidence is mixed: gross margin 57.2% vs 81.1%; operating margin 12.1% vs -9.2%; ttm roe 1.9% vs 0.3%. CNMD leads on two measures and GKOS on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is CNMD's lead over GKOS getting stronger or weaker?
CNMD lead: Weakening — the AIQ differential moved from 9 to 6 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has not changed hands in that window.
What would change the CNMD vs GKOS verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: GKOS closes the Value gap — currently 54 points behind, the largest single contributor to CNMD's edge; GKOS generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover; CNMD's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 6-point move would eliminate CNMD's advantage entirely.
What do the current signals say about CNMD and GKOS?
CNMD: 4 bullish / 1 bearish / 2 neutral, conflicted. GKOS: 6 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CNMD is Golden Cross Active (bullish, long horizon). On GKOS it is Golden Cross Active (bullish, long horizon).
Compare CNMD and GKOS with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.